Yungjin Pharm. Co., Ltd. (KRX:003520)
South Korea · Delayed Price · Currency is KRW 1,223.00
+3.00 (0.25%)
Jul 27, 2026, 1:45 PM KST
Yungjin Pharm. Market Cap
Yungjin Pharm. has a market cap or net worth of 223.13 billion as of July 24, 2026. Its market cap has decreased by -44.16% in one year.
Market Cap
223.13B
Enterprise Value
n/a
Revenue
158.79B
Ranking
n/a
PE Ratio
22.81
Stock Price
1,223.00
ChartMarket Cap Chart
Since April 16, 1993, Yungjin Pharm.'s market cap has increased from 61.80B to 223.13B, an increase of 261.03%. That is a compound annual growth rate of 3.93%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 223.13B | -39.00% |
| Dec 30, 2025 | 365.78B | 0.60% |
| Dec 30, 2024 | 363.59B | -6.45% |
| Dec 28, 2023 | 388.65B | -34.62% |
| Dec 29, 2022 | 594.40B | -38.56% |
| Dec 30, 2021 | 967.50B | -34.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EuBiologics | 283.73B |
| JW Holdings | 267.08B |
| Humedix | 254.91B |
| Korea United Pharm | 249.93B |
| Suheung | 231.07B |
| Boditech Med | 222.78B |
| Samjin Pharmaceuticals | 219.05B |
| Chong Kun Dang Holdings | 186.38B |